A Study of EDG-7500 in Adults With Hypertrophic Cardiomyopathy (CIRRUS-HCM)
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCSF
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Edgewise Therapeutics, Inc.
- ID
- NCT06347159
- Phase
- Phase 2 Cardiomyopathy Research Study
- Study Type
- Interventional
- Participants
- Expecting 55 study participants
- Last Updated